BioRestorative Therapies, Inc. (BRTX) Starts Presentation at 2015 Marcum MicroCap Conference

BioRestorative Therapies develops products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company’s lead cell therapy candidate, brtxDISC™, is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow intend for use in the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The company is also developing an allogeneic cell-based therapy to target obesity and metabolic disorders. For more information, visit the company’s website at www.biorestorative.com.